| |
|
|
|
Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814, USA
June 25-26, 2015
The optimization of pre-analytical/pre-detection processing should closely follow or even precede the emergence of new omics assays. Innovative sample prep and target enrichment technologies have the ability to significantly increase the sensitivity and specificity of a test that is run on a heterogeneous sample or a sample that contains low concentration of an analyte. Appropriate and novel sample preparation is a pivotal part of assay development and validation that guarantees its repeatability and robustness. The ninth annual Sample Prep Technologies conference is designed to discuss the major challenges and the latest advances in sample preparation for advanced omics assays in clinic as well as in biodetection and biosurveillance fields.
|
|
|
|
|
|
|
|
Organized by:
|
|
Knowledge Foundation, a division of CHI |
|
|
Invited Speakers:
|
|
- Scott D. Jewell, Ph.D., Professor and Director, Program for Technologies and Cores Van Andel Research Institute
- Randy Rasmussen, Ph.D., President and COO, BioFire Diagnostics
- Stephanie Thatcher, Ph.D., Director, Systems Integration, BioFire Diagnostics
- Lawrence B. Blyn, Ph.D., Director, Science and Technology, Ibis Biosciences, Abbott
- Patrick Hurban, Ph.D., Vice President, Research and Development, Expression Analysis, The Quintiles Company
- Robert D. Daber, Ph.D., Director, Research and Development and Sequencing Operations, Bio-Reference Laboratories
- P. Mickey Williams, Ph.D., Director, Molecular Characterization & Clinical Assay Development Laboratory (MoCha), Frederick National Laboratory for Cancer Research
- Curt Scharfe, M.D., Ph.D., Senior Scientist, Stanford Genome Technology Center, Stanford University
- Chalom Sayada, M.D., Ph.D., Co-founder & CEO, Advanced Biological Laboratories SA
- Helen Moore, Ph.D., Branch Chief, Biorepositories & Biospecimen Research Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute
- Helen Fernandes, Ph.D., Associate Professor, Pathology and Laboratory Medicine, Weill Cornell Medical College
- Alexis Sauer-Budge, Ph.D., Senior Research Scientist, Fraunhofer Center for Manufacturing Innovation; Adjunct Research Assistant Professor, Biomedical Engineering, Boston University
- Sam R. Nugen, Ph.D., Assistant Professor, Department of Food Science, University of Massachusetts, Amherst
- Patricia Mueller, Ph.D., Chief, Molecular Risk Assessment Laboratory, Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences, Centers for Disease Control and Prevention (CDC)
- Apurva K. Srivastava, Ph.D., Principal Scientist, Frederick National Laboratory for Cancer Research Leidos Biomedical Research, Inc.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
---
|
|
|
|
|
|
|
|
Registration:
|
|
Register Now
|
|
|
E-mail:
|
|
custserv@knowledgefoundation.com
|
|
|
|
|
|
|
|
|